Alzheimer's disease (AD) and Parkinson's disease (PD) are the most prevalent
neurodegenerative diseases, affecting millions and costing billions each year in the United …

Administration of levodopa for Parkinson's disease (PD) has remained the most effective
therapy for symptom management despite being in use for over 50 years. Advancing …

The intestinal flora has become very active in studies related to Parkinson's disease (PD) in
recent years. The microbe‐gut‐brain axis is closely related to the maintenance of brain …

The adenosine A 2A receptor antagonist/inverse agonist, KW-6356 has been shown to be
effective in Parkinson's disease (PD) patients as monotherapy and as an adjunct therapy to …

Aggregation of α-synuclein into toxic oligomeric structures has been implicated in the
pathogenesis of Parkinson's disease via several key stages of fibrillation, oligomerization …

Statins have been proposed for L-DOPA-induced dyskinesia (LID) treatment. Statin anti-
dyskinetic effects were related to the inhibition of the Ras-ERK pathway. However, the …

Parkinson's disease is second most common neurodegenerative disorder neurological
illness that primarily affects patients in their later years of life. Specific neurons in the brain …

To boost the enzyme-like activity, biological compatibility, and antiaggregation effect of
noble-metal-based nanozymes, folic-acid-strengthened Ag–Ir quantum dots (FA@ Ag–Ir …

To reliably monitor dopamine (DA), a common neurotransmitter, a kind of nano CeO 2/CuO
modified carboxylated chitosan nanozyme (CeO 2/CuO@ CC) was constructed under …

Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor
dysfunction due to the death of dopaminergic neurons in the substantia nigra pars …